Burr Alert: Areas of Unique Legal Concerns and Solutions in Device M&A

Articles / Publications


With medical device related acquisitions at all-time highs, and regulatory interest intense from the Federal Trade Commission, the Food and Drug Administration, the Securities and Exchange Commission, and the Office of Inspector General for the Department of Health and Human Services, acquiring companies must exercise extreme diligence and due care in structuring, documenting and consummating acquisitions.

Conventional challenges with mergers and acquisitions include identification of suitable complementary targets, due diligence development and risk assessment, valuation and payment, optimal structure, liability exposure and tax treatment, assumed and excluded assets and liabilities, representations and warranties, pre-closing and post-closing covenants, closing timelines and conditions, and termination. There exists a well-established body of principles, terms and documents addressing these problems.

Download the full article, "Areas of Unique Legal Concerns and Solutions in Device M&A".


Related Professionals

Jump to Page
Arrow icon Top

Contact Us

We use cookies to improve your website experience, provide additional security, and remember you when you return to the website. This website does not respond to "Do Not Track" signals. By clicking "Accept," you agree to our use of cookies. To learn more about how we use cookies, please see our Privacy Policy.

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. These cookies may only be disabled by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.